Dr. Chi Chi, the lead author of the article entitled, “HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells” (by Chi Chi, Min Mao, Zongji Shen, Youguo Chen, Jie Chen, and Wenjie Hou, Hum Gene Ther 2018;29(12):1438–1448; doi: 10.1089/hum.2017.256) requested that their published article in Human Gene Therapy be officially retracted due to their recent inability to repeat the results of the experiments in the study.
An email from Dr. Chi received by the editorial office read, “My co-authors and I recently repeated the experiments and found some differences compared to the previous study results, which drew our great attention. For the rigor of scientific research, we have to [retract] our manuscript and need more time to verify the final results. We [are] sorry for this decision…”
After reviewing the circumstances and seeking all authors' agreement, the editorial leadership of the journal agreed to retract the article.
Human Gene Therapy is committed to upholding the rigorous standards of scientific publishing and the veracity of the literature.